Background: Language discordance occurs when the patient and the healthcare provider are not proficient in the same language. Language discordance in the critical care setting is a significant global issue because of its implications in the quality of care and outcomes of patients who do not speak the primary language of the country in which they receive healthcare. Studies show that language-discordant, critically ill patients have increased use of restraints during mechanical ventilation, increased length of stay, and more frequent complications. Communication challenges are magnified in the intensive care unit because of the medical complexity and frequent need for challenging conversations regarding goals of care. To address language-based disparities in critical care, numerous qualitative studies in recent years have attempted to understand the barriers that providers face when caring for language-discordant patients. Our systematic review is the first to analyze this developing body of literature and identify barriers for which solutions must be sought to ensure equitable care. Methods: This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched PubMed, Embase, and Scopus from inception up to 20 February 2024. From among 2150 articles, nine articles were selected, which included eight qualitative studies and one cross-sectional study. Three studies were high quality, five were moderate quality, and one was low quality. Results: We found four major barriers to caring for language-discordant patients in the critical care setting. These included limitations in providers’ knowledge of best practices in professional medical interpreter use, challenges in navigating interpreters’ multiple roles, and limitations with different interpretive modalities and system constraints. These barriers caused clinicians distress due to clinicians’ desire to provide empathic care that respected patients’ autonomy and ensured patients’ safety and understanding. Conclusion: Interventions to increase providers’ knowledge of best practices, integrate interpreters into the critical care team, strategize the use of interpretation modalities, and address system-based barriers are needed to improve the care of language-discordant, critically ill patients worldwide.
6 March 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Ibuprofen, a non-steroidal anti-inflammatory drug, can increase the risk of bleeding, a significant concern in burn surgery, which often involves substantial blood loss. This study aims to evaluate the safety of ibuprofen use in burn patients undergoing skin grafting. A retrospective case-control chart review was conducted for patients admitted with acute burn injury from January 1, 2024 to July 31, 2024 who underwent skin grafting. The primary outcome variables included perioperative transfusion requirement, bleeding, skin graft failure, and other complications. A total of 53 patients met the inclusion criteria, 24 (45.2%) of whom received scheduled ibuprofen therapy during their hospitalization. The total body surface area affected was 12.3 ± 9.3% for the non-ibuprofen group and 14.3 ± 12.1% for the ibuprofen group (P = .62). A total of 79.3% of patients in the non-ibuprofen group received meshed grafts compared to 79.2% in the ibuprofen group (P = .734). Perioperative transfusion requirements were similar between the 2 cohorts, averaging 4.6 ± 3.1 for the non-ibuprofen group and 3.2 ± 2.8 units of packed red blood cells for the ibuprofen group (P = .207). Skin graft failure (defined as the need for re-grafting) occurred in 6.9% (n = 2) of the non-ibuprofen cohort vs none (n = 0) in the ibuprofen group (P = .112). Postoperative complications did not vary significantly between the 2 groups for seroma (P = .259), hematoma (P = .498), and infection (P = .568). There were no cases of hypersensitivity or gastrointestinal bleeding. There is likely no increased risk of bleeding or skin graft failure in burn injury patients taking ibuprofen, suggesting that these medications may be safe in this context.
Stimulant use poses significant challenges in burn care, complicating pain management and leading to poorer outcomes, including longer hospital stays, higher complication rates, and increased healthcare costs. This study evaluates burn-related outcomes in stimulant-positive patients, as well as tabulates how frequently addiction medicine consultations are used in burn patients with positive stimulant screens. Patients with positive urine toxicology screens for stimulants, including amphetamines and cocaine, were identified. The primary predictor variable was stimulant use, while primary outcomes included length of hospital stay, burn severity, complications, and overall outcomes of care. Out of 3403 burn patients (34% female, 66% male, with a mean age of 39.2 ± 22.8 years), 572 patients (16.8%) had positive urine toxicology screens for stimulants. Stimulant-positive patients had significantly longer hospital stays compared to stimulant-negative patients (17.7 vs. 10.7 days, P < .001), more severe burns (P = .001), and a higher incidence of complications (15.6% vs. 11.5%, P = .006). Despite these risks, only 12.6% (72 patients) of stimulant-positive burn patients received an addiction medicine consultation during their hospitalization. The use of addiction medicine consultations increased over time, rising from 3 consults in 2015 to 42 in 2023. A multidisciplinary approach that includes addiction medicine can help address both the complexities of pain management and substance use, leading to improved patient outcomes. Early involvement of addiction medicine could enhance pain management and recovery, emphasizing the need for more systematic integration of addiction medicine into burn care protocols.
5 November 2025 in Journal of Reconstructive Microsurgery
Formal dangling protocols are often used after lower extremity free flap reconstruction to acclimate flaps to gravitational stress. However, their clinical benefit remains uncertain. This study evaluates how the inclusion or omission of structured inpatient dangling affects flap outcomes. A retrospective review was conducted of 82 patients who underwent lower extremity free flap reconstruction at a single institution (2015–2024). Patients were grouped based on use of a formal dangling protocol (≥3 consecutive supervised sessions beginning after postoperative day 5) versus no protocol (ad libitum dangling beginning day 3). Outcomes included flap survival, complications, 30-day unplanned reoperation, time to ambulation, and length of stay. Statistical analysis included chi-squared, t-tests, and multivariable regression models. Fifty-three patients adhered to a dangle protocol; 29 did not follow a protocol. Demographics, comorbidities, flap type, and defect characteristics were similar between groups. Flap survival (96.2% vs. 96.6%, p = 0.94), partial necrosis (9.4% vs. 10.3%, p = 0.89), and reoperation rates (3.4% vs. 7.5%, p = 0.46) were comparable. On multivariable analysis, dangle protocol use was not associated with reduced complication risk (OR = 0.95, p = 0.93) but was associated with a 3.0-day longer median hospital stay (p < 0.01). The application of a formal dangling protocol did not affect flap survival but was independently associated with prolonged hospitalization. These findings challenge the necessity of structured regimens and support more patient-tailored postoperative strategies that may accelerate recovery without compromising surgical outcomes.